How schools can adapt to flexible learning
Sophie Barclay was 15 when diagnosed with a brain tumour, making schooling and exams difficult. Now 18, she tells us how, with the support of her school, she has received a conditional offer for university.
Educational support pathway after brain tumour treatment
Louise Robinson is a neuro-oncology outreach nurse specialist at East Midlands Children’s and Young Persons’ Integrated Cancer Service. Here, she emphasises the importance of collaboration and explains how a support pathway helps young patients with their education.
60 seconds with Gail Beaumont
Gail Beaumont, a dedicated hospital teacher at Sheffield Children’s Hospital, shares insights into her unique role in providing education and support to young patients during their hospital stays.
How robots are being used to support learning
Charlotte Bowling's daughter, Amelie, was diagnosed with acute lymphoblastic leukaemia (ALL) in June 2019 aged six. Charlotte tells us about the support her daughter and her family received from her school, including an innovative way of ensuring Amelie was involved even when not physically present.
Why working together is so important
Naomi Duxbury’s daughter, Mia, was aged four when diagnosed with B-cell acute lymphoblastic leukaemia in September 2021. Here, she tells us about the importance of working closely with Mia’s school to create a safe, supportive and ‘normal’ learning environment for her.
"The first day back at school was scary, but exciting"
Lily Morris was diagnosed with acute lymphoblastic leukaemia (ALL) in 2022 aged 15. Now 16, she tells us about its impact on her GCSE preparations, and the support she’s received from her school and friends as she transitioned back into full-time education.
Ask the Expert: Emily Varley
Emily Varley, a school special educational needs and disabilities coordinator (SENDCo) based in Leicestershire
New initiative supports young cancer patients with additional needs
Children with cancer who also have learning difficulties and autism often have additional needs when it comes to their care. Jeanette Hawkins, CCLG’s Chief Nurse, tells us more about a project aiming to improve support for this group of patients.
Therapeutic drug monitoring: A novel approach to improving treatment
Gareth Veal, Professor of Cancer Pharmacology at the Newcastle University Cancer Centre, leads a team helping doctors to personalise treatments through an innovative process called ‘therapeutic drug monitoring’. Here, he tells us more about his work.